A policy change allowing approval of some new drugs based on one adequate and well-controlled study could accelerate ...

Makary pointed to three bottlenecks: hospital contracting; ethical reviews and approvals; and the Investigational New Drug applications process ...

MSD will integrate clinical insights and genomic datasets from Mayo Clinic Platform, aggregating data in a secure environment ...

And there's more than one way to monetize this technology.

On Dec 19, 2025, the US Food and Drug Administration (FDA) announced a major milestone by qualifying total hip bone mineral density (BMD), assessed by dual-energy X-ray absorptiometry, as a surrogate ...

Drug Development Lessons for 2026 Drawn from 2025 Realities, Upcoming Webinar Hosted by Xtalks ...

Add Yahoo as a preferred source to see more of our stories on Google. A new analysis of 341 pivotal drug trials shows that only a tiny fraction reflect the racial and ethnic mix of the United States.

A triple combination therapy identified using newly developed cell models is showing promise for treating sporadic ALS, per a study.

Sanofi's incoming CEO, 65-year-old Belén Garijo, faces a major task to win over investors, accelerate the French company's ...

Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of ...

Balasegaram is executive director of the Global Antibiotic Research & Development Partnership. No matter how carefully we use the antibiotics we have, drug resistant infections will continue to gain ...